Mannose-Binding Lectin Reduces Oxidized Low-Density Lipoprotein Induced Vascular Endothelial Cells Injury by Inhibiting LOX1-ox-LDL Binding and Modulating Autophagy

Abstract: Objective: To investigate the role of mannose-binding lectin (MBL) in modulating autophagy and protecting endothelial cells (ECs) from oxidized low-density lipoprotein (ox-LDL)-induced injury. Methods: Serum MBL concentration and carotid intima-media thickness (cIMT) were measured in 94 obese and 105 healthy children. ECs were transfected with MBL over-expression plasmid, LOX1 was knocked-down to explore the protective role of MBL in ox-LDL induced ECs injury. Dendritic cells (DCs) were co-cultured with ECs, and inflammatory factors, DC maturation, and autophagy was assessed. WT and ApoE−/− mice were fed with a high fat diet (HFD) with or without MBL-adenovirus injection for 16 weeks and aortic vascular endothelial tissue was isolated, then atherosclerotic plaque, cell injury and autophagy were analyzed. Results: Serum MBL concentration in obese children was lower than healthy controls and was negatively correlated with cIMT. The uptake of ox-LDL was decreased in LOX1 knock-down ECs. MBL over-expression in vitro inhibited LOX1-ox-LDL binding. Both LOX1 knock-down and MBL over-expression can ameliorate EC autophagy and cell injury. MBL over-expression in vivo alleviated atherosclerotic plaque formation, influenced DC maturation and down-regulated IL-6, IL-12, and TNF-a levels. Conclusions: MBL exerts a protective role in ox-LDL-induced EC injury by modulating DC maturation and EC autophagy via inhibiting LOX1-ox-LDL binding.

[1]  K. Ley,et al.  How the immune system shapes atherosclerosis: roles of innate and adaptive immunity , 2021, Nature Reviews Immunology.

[2]  Dong Yan,et al.  Identification of potential therapeutic targets for atherosclerosis by analysing the gene signature related to different immune cells and immune regulators in atheromatous plaques , 2021, BMC medical genomics.

[3]  Dong Yan,et al.  Identification of potential therapeutic targets for atherosclerosis by analysing the gene signature related to different immune cells and immune regulators in atheromatous plaques , 2021, BMC Medical Genomics.

[4]  V. Deretic.  Autophagy in inflammation, infection, and immunometabolism. , 2021, Immunity.

[5]  Jianghua Chen,et al.  Mannose-binding lectin activation is associated with the progression of diabetic nephropathy in type 2 diabetes mellitus patients , 2020, Annals of translational medicine.

[6]  I. Brandslund,et al.  Mannose-Binding Lectin and Risk of Cardiovascular Events and Mortality in Type 2 Diabetes: A Danish Cohort Study , 2020, Diabetes Care.

[7]  J. Y. Takada,et al.  Prospective, case-controlled study evaluating serum concentration of sirtuin-1 and mannose-binding lectin in patients with and without periodontal and coronary artery disease , 2020, Therapeutic advances in chronic disease.

[8]  Jie Ren,et al.  The responses of the gut microbiota to MBL deficiency. , 2020, Molecular immunology.

[9]  Lili Yu,et al.  Regulation and mechanism of mannan-binding lectin (MBL) on adipogenic differentiation of 3T3-L1 preadipocytes , 2020 .

[10]  A. Sikalidis,et al.  The Gut Microbiome and Type 2 Diabetes Mellitus: Discussing A Complex Relationship , 2020, Biomedicines.

[11]  S. Fumagalli,et al.  Mannose-binding lectin has a direct deleterious effect on ischemic brain microvascular endothelial cells , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  Z. Mallat,et al.  Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[13]  Chen Chen,et al.  Mannan-Binding Lectin Suppresses Peptidoglycan-Induced TLR2 Activation and Inflammatory Responses , 2019, Mediators of inflammation.

[14]  Dong Zhao,et al.  Epidemiology of cardiovascular disease in China: current features and implications , 2018, Nature Reviews Cardiology.

[15]  J. Clemente,et al.  Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease , 2018, Front. Physiol..

[16]  M. Bennett,et al.  Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis , 2018, Cardiovascular research.

[17]  Kenzo Hokazono,et al.  Mannose Binding Lectin and Pentraxin 3 in Patients with Diabetic Retinopathy. , 2018, Archives of medical research.

[18]  K. Yan,et al.  LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription , 2018, Nature Communications.

[19]  Mohammad Hossein Khosravi,et al.  Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.

[20]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[21]  G. Johansson,et al.  Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment , 2017, Preventive medicine reports.

[22]  B. Amundsen,et al.  Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. , 2016, European heart journal.

[23]  S. Thiel,et al.  Oligomerization of Mannan‐binding Lectin Dictates Binding Properties and Complement Activation , 2016, Scandinavian journal of immunology.

[24]  E. Feskens,et al.  Distinct Longitudinal Associations of MBL, MASP-1, MASP-2, MASP-3, and MAp44 With Endothelial Dysfunction and Intima–Media Thickness: The Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Matthew B. Dong,et al.  Flow cytometric gating for spleen monocyte and DC subsets: differences in autoimmune NOD mice and with acute inflammation. , 2016, Journal of immunological methods.

[26]  M. Papp,et al.  Mannose-Binding Lectin Levels and Carotid Intima-Media Thickness in Type 2 Diabetic Patients , 2015, Journal of diabetes research.

[27]  Daming Zuo,et al.  Mannan‐binding lectin at supraphysiological concentrations inhibits differentiation of dendritic cells from human CD14+ monocytes , 2015, Microbiology and immunology.

[28]  F. Romeo,et al.  Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells: Role of oxidative stress and LOX-1 receptor expression. , 2015, International journal of cardiology.

[29]  Yongjun Cao,et al.  Autophagy in Atherosclerosis: A Phenomenon Found in Human Carotid Atherosclerotic Plaques , 2015, Chinese medical journal.

[30]  E. Nahas,et al.  Mannose-binding lectin gene polymorphism and risk factors for cardiovascular disease in postmenopausal women. , 2014, Molecular immunology.

[31]  G. Norata,et al.  LOX-1, OxLDL, and Atherosclerosis , 2013, Mediators of inflammation.

[32]  Yubo Fan,et al.  Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression , 2013, Scientific Reports.

[33]  L. Vatten,et al.  Mannose-Binding Lectin Deficiency Is Associated with Myocardial Infarction: The HUNT2 Study in Norway , 2012, PloS one.

[34]  Jennifer Martinez,et al.  Macrophage autophagy plays a protective role in advanced atherosclerosis. , 2012, Cell metabolism.

[35]  Mark Woodward,et al.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .

[36]  Xiao Lu,et al.  Mannan-binding lectin regulates dendritic cell maturation and cytokine production induced by lipopolysaccharide , 2011, BMC Immunology.

[37]  A. Tenner,et al.  Innate Immune Proteins C1q and Mannan-Binding Lectin Enhance Clearance of Atherogenic Lipoproteins by Human Monocytes and Macrophages , 2010, The Journal of Immunology.

[38]  B. Krebs,et al.  oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. , 2009, Atherosclerosis.

[39]  K. Takahashi,et al.  Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype , 2005, The Journal of Immunology.

[40]  L. Stuart,et al.  Mannose-Binding Lectin-Deficient Mice Display Defective Apoptotic Cell Clearance but No Autoimmune Phenotype1 , 2005, The Journal of Immunology.

[41]  J. J. Batenburg,et al.  Collectins: players of the innate immune system. , 2004, European journal of biochemistry.

[42]  B. Amundsen,et al.  Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial † , 2016 .